![David Piacquad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 37 185 $ in data 31/05/2026
David A. Piacquad is currently an Independent Director at Angitia Biopharmaceuticals Guangzhou Ltd. and an Independent Director at Neumora Therapeutics, Inc. since 2023.
Former positions include Senior VP-Business Development & Licensing at Schering-Plough Corp.
from 2006 to 2009, Vice President-Licensing & Acquisitions at McNeil Consumer & Specialty Pharmaceuticals, Inc., Vice President-Ventures & Business Development at Johnson & Johnson, Inc., Principal at Mr. Piacquad Consulting LLC in 2010, and Senior Vice President-Business Development at Amgen, Inc. from 2014 to 2022.
Education includes an undergraduate degree from Colgate University and an MBA from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/05/2026 | 20.100 ( 0,01% ) | 37 185 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2023 |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/02/2022 |
David A. Piacquad Consulting LLC | Corporate Officer/Principal | 01/06/2010 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01/12/2009 |
Johnson & Johnson, Inc.
 Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Corporate Officer/Principal | - |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
 McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Health Technology |
Johnson & Johnson, Inc.
Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David A. Piacquad Consulting LLC | |
Angitia Biopharmaceuticals Guangzhou Ltd.
Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
